Vericare - Medicare Mental Health Clinic in Lakeland, FL

Vericare is a medicare enrolled mental health clinic (Psychologist - Clinical) in Lakeland, Florida. The current practice location for Vericare is 4240 Lakeland Highlands Rd, Lakeland, Florida. For appointments, you can reach them via phone at (800) 257-8715. The mailing address for Vericare is 55 Hatchetts Hill Rd, Old Lyme, Connecticut and phone number is (800) 370-3651.

Vericare is licensed to practice in Florida (license number ). The clinic also participates in the medicare program and its NPI number is 1851331086. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (800) 257-8715.

Contact Information

Vericare
4240 Lakeland Highlands Rd
Lakeland
FL 33813-3113
(800) 257-8715
(800) 819-1655

Mental Health Clinic Profile

Full NameVericare
SpecialityPsychologist
Location4240 Lakeland Highlands Rd, Lakeland, Florida
Authorized Official Name and PositionMelissa King (DIRECTOR OF CREDENTIALING & ENROLLM)
Authorized Official Contact8003703651
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Vericare
55 Hatchetts Hill Rd
Old Lyme
CT 06371-1534

Ph: (800) 370-3651
Vericare
4240 Lakeland Highlands Rd
Lakeland
FL 33813-3113

Ph: (800) 257-8715

NPI Details:

NPI Number1851331086
Provider Enumeration Date06/07/2006
Last Update Date07/11/2017

Medicare PECOS Information:

Medicare PECOS PAC ID7416854468
Medicare Enrollment IDO20031217000566

News Archive

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists at The Scripps Research Institute have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex. The largest and most recently evolved region of the brain, the neocortex is particularly well developed in humans and is responsible for sensory processing, long-term memory, reasoning, complex muscle actions, consciousness and other functions.

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

Viewpoints: Dems vs. Ryan on entitlement cuts; defending planned parenthood

Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.

Read more Medical News

› Verified 1 days ago

Medical Identifiers

Medical identifiers for Vericare such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1851331086NPI-NPPES
CJ2290OtherCARAILROAD MEDICARE
38509OtherFLBLUE CROSS BLUE SHIELD

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
103TC0700XPsychologist - Clinical (Florida)Primary
1041C0700XSocial Worker - Clinical (Florida)Secondary
2084P0800XPsychiatry & Neurology - Psychiatry (Florida)Secondary
363LP0808XNurse Practitioner - Psychiatric/mental Health (Florida)Secondary
364SP0808XClinical Nurse Specialist - Psychiatric/mental Health (Florida)Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Vericare acts as a billing entity for following providers:
Provider NameLinda B Munday
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1932196680
PECOS PAC ID: 0042299265
Enrollment ID: I20040720000257

News Archive

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists at The Scripps Research Institute have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex. The largest and most recently evolved region of the brain, the neocortex is particularly well developed in humans and is responsible for sensory processing, long-term memory, reasoning, complex muscle actions, consciousness and other functions.

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

Viewpoints: Dems vs. Ryan on entitlement cuts; defending planned parenthood

Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.

Read more Medical News

› Verified 1 days ago

Provider NameCristina M Mejia Millan
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1194820795
PECOS PAC ID: 6608834817
Enrollment ID: I20050216000573

News Archive

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists at The Scripps Research Institute have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex. The largest and most recently evolved region of the brain, the neocortex is particularly well developed in humans and is responsible for sensory processing, long-term memory, reasoning, complex muscle actions, consciousness and other functions.

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

Viewpoints: Dems vs. Ryan on entitlement cuts; defending planned parenthood

Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.

Read more Medical News

› Verified 1 days ago

Provider NameRachel Harper
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1649267097
PECOS PAC ID: 7214970623
Enrollment ID: I20050607000540

News Archive

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists at The Scripps Research Institute have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex. The largest and most recently evolved region of the brain, the neocortex is particularly well developed in humans and is responsible for sensory processing, long-term memory, reasoning, complex muscle actions, consciousness and other functions.

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

Viewpoints: Dems vs. Ryan on entitlement cuts; defending planned parenthood

Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.

Read more Medical News

› Verified 1 days ago

Provider NameAgnes Tolentino
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1669589891
PECOS PAC ID: 4082649405
Enrollment ID: I20051004000662

News Archive

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists at The Scripps Research Institute have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex. The largest and most recently evolved region of the brain, the neocortex is particularly well developed in humans and is responsible for sensory processing, long-term memory, reasoning, complex muscle actions, consciousness and other functions.

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

Viewpoints: Dems vs. Ryan on entitlement cuts; defending planned parenthood

Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.

Read more Medical News

› Verified 1 days ago

Provider NameElizabeth A Handte
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1144293168
PECOS PAC ID: 3476572413
Enrollment ID: I20051118000182

News Archive

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists at The Scripps Research Institute have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex. The largest and most recently evolved region of the brain, the neocortex is particularly well developed in humans and is responsible for sensory processing, long-term memory, reasoning, complex muscle actions, consciousness and other functions.

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

Viewpoints: Dems vs. Ryan on entitlement cuts; defending planned parenthood

Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.

Read more Medical News

› Verified 1 days ago

Provider NameScott M Costanza
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1336354752
PECOS PAC ID: 7416043021
Enrollment ID: I20071012000179

News Archive

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists at The Scripps Research Institute have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex. The largest and most recently evolved region of the brain, the neocortex is particularly well developed in humans and is responsible for sensory processing, long-term memory, reasoning, complex muscle actions, consciousness and other functions.

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

Viewpoints: Dems vs. Ryan on entitlement cuts; defending planned parenthood

Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.

Read more Medical News

› Verified 1 days ago

Provider NameChrista H Sedney
Provider TypePractitioner - Certified Clinical Nurse Specialist (cns)
Provider IdentifiersNPI Number: 1598872384
PECOS PAC ID: 6204870751
Enrollment ID: I20081021000410

News Archive

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists at The Scripps Research Institute have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex. The largest and most recently evolved region of the brain, the neocortex is particularly well developed in humans and is responsible for sensory processing, long-term memory, reasoning, complex muscle actions, consciousness and other functions.

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

Viewpoints: Dems vs. Ryan on entitlement cuts; defending planned parenthood

Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.

Read more Medical News

› Verified 1 days ago

Provider NameMichael A Coulter
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1194031880
PECOS PAC ID: 0547386021
Enrollment ID: I20100922000790

News Archive

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists at The Scripps Research Institute have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex. The largest and most recently evolved region of the brain, the neocortex is particularly well developed in humans and is responsible for sensory processing, long-term memory, reasoning, complex muscle actions, consciousness and other functions.

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

Viewpoints: Dems vs. Ryan on entitlement cuts; defending planned parenthood

Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.

Read more Medical News

› Verified 1 days ago

Provider NameTamara Haberman
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1407119548
PECOS PAC ID: 7618133646
Enrollment ID: I20120719000357

News Archive

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists at The Scripps Research Institute have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex. The largest and most recently evolved region of the brain, the neocortex is particularly well developed in humans and is responsible for sensory processing, long-term memory, reasoning, complex muscle actions, consciousness and other functions.

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

Viewpoints: Dems vs. Ryan on entitlement cuts; defending planned parenthood

Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.

Read more Medical News

› Verified 1 days ago

Provider NameSharon M Jacob
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1487903605
PECOS PAC ID: 1557511524
Enrollment ID: I20121029000322

News Archive

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists at The Scripps Research Institute have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex. The largest and most recently evolved region of the brain, the neocortex is particularly well developed in humans and is responsible for sensory processing, long-term memory, reasoning, complex muscle actions, consciousness and other functions.

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

Viewpoints: Dems vs. Ryan on entitlement cuts; defending planned parenthood

Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.

Read more Medical News

› Verified 1 days ago

Provider NameSherron Lurline Miller
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1922352905
PECOS PAC ID: 7618129248
Enrollment ID: I20121206000263

News Archive

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists at The Scripps Research Institute have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex. The largest and most recently evolved region of the brain, the neocortex is particularly well developed in humans and is responsible for sensory processing, long-term memory, reasoning, complex muscle actions, consciousness and other functions.

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

Viewpoints: Dems vs. Ryan on entitlement cuts; defending planned parenthood

Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.

Read more Medical News

› Verified 1 days ago

Provider NameManuel Alvarez
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1386718062
PECOS PAC ID: 0941242564
Enrollment ID: I20130814000592

News Archive

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists at The Scripps Research Institute have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex. The largest and most recently evolved region of the brain, the neocortex is particularly well developed in humans and is responsible for sensory processing, long-term memory, reasoning, complex muscle actions, consciousness and other functions.

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

Viewpoints: Dems vs. Ryan on entitlement cuts; defending planned parenthood

Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.

Read more Medical News

› Verified 1 days ago

Provider NameMary Louise Hudson Ray
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1669804258
PECOS PAC ID: 5092959155
Enrollment ID: I20130912000070

News Archive

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists at The Scripps Research Institute have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex. The largest and most recently evolved region of the brain, the neocortex is particularly well developed in humans and is responsible for sensory processing, long-term memory, reasoning, complex muscle actions, consciousness and other functions.

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

Viewpoints: Dems vs. Ryan on entitlement cuts; defending planned parenthood

Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.

Read more Medical News

› Verified 1 days ago

Provider NameJudy E Snow
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1831488410
PECOS PAC ID: 6406073832
Enrollment ID: I20140808000797

News Archive

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists at The Scripps Research Institute have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex. The largest and most recently evolved region of the brain, the neocortex is particularly well developed in humans and is responsible for sensory processing, long-term memory, reasoning, complex muscle actions, consciousness and other functions.

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

Viewpoints: Dems vs. Ryan on entitlement cuts; defending planned parenthood

Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.

Read more Medical News

› Verified 1 days ago

Provider NameRyan W Macalua
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1174919377
PECOS PAC ID: 4880975911
Enrollment ID: I20170104001801

News Archive

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists at The Scripps Research Institute have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex. The largest and most recently evolved region of the brain, the neocortex is particularly well developed in humans and is responsible for sensory processing, long-term memory, reasoning, complex muscle actions, consciousness and other functions.

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

Viewpoints: Dems vs. Ryan on entitlement cuts; defending planned parenthood

Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.

Read more Medical News

› Verified 1 days ago

Provider NameMichael Hoffman
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1578919973
PECOS PAC ID: 8426100199
Enrollment ID: I20170426002714

News Archive

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists at The Scripps Research Institute have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex. The largest and most recently evolved region of the brain, the neocortex is particularly well developed in humans and is responsible for sensory processing, long-term memory, reasoning, complex muscle actions, consciousness and other functions.

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

Viewpoints: Dems vs. Ryan on entitlement cuts; defending planned parenthood

Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.

Read more Medical News

› Verified 1 days ago

Provider NameKarem Cando Rovira
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1790893949
PECOS PAC ID: 7911913603
Enrollment ID: I20171017003456

News Archive

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists at The Scripps Research Institute have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex. The largest and most recently evolved region of the brain, the neocortex is particularly well developed in humans and is responsible for sensory processing, long-term memory, reasoning, complex muscle actions, consciousness and other functions.

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

Viewpoints: Dems vs. Ryan on entitlement cuts; defending planned parenthood

Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.

Read more Medical News

› Verified 1 days ago

Provider NameTamara Martinez Morales
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1336572478
PECOS PAC ID: 8426316522
Enrollment ID: I20171219001771

News Archive

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists at The Scripps Research Institute have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex. The largest and most recently evolved region of the brain, the neocortex is particularly well developed in humans and is responsible for sensory processing, long-term memory, reasoning, complex muscle actions, consciousness and other functions.

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

Viewpoints: Dems vs. Ryan on entitlement cuts; defending planned parenthood

Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.

Read more Medical News

› Verified 1 days ago

Provider NameSheeba Rahman
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1023285848
PECOS PAC ID: 7214183680
Enrollment ID: I20180709003259

News Archive

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists at The Scripps Research Institute have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex. The largest and most recently evolved region of the brain, the neocortex is particularly well developed in humans and is responsible for sensory processing, long-term memory, reasoning, complex muscle actions, consciousness and other functions.

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

Viewpoints: Dems vs. Ryan on entitlement cuts; defending planned parenthood

Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.

Read more Medical News

› Verified 1 days ago

Provider NameMarinette Asuncion-uy
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1477880326
PECOS PAC ID: 0042561508
Enrollment ID: I20180921001173

News Archive

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists at The Scripps Research Institute have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex. The largest and most recently evolved region of the brain, the neocortex is particularly well developed in humans and is responsible for sensory processing, long-term memory, reasoning, complex muscle actions, consciousness and other functions.

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

Viewpoints: Dems vs. Ryan on entitlement cuts; defending planned parenthood

Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.

Read more Medical News

› Verified 1 days ago

Provider NameMartha Dedricks
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1144453036
PECOS PAC ID: 7315282373
Enrollment ID: I20181219000899

News Archive

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists at The Scripps Research Institute have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex. The largest and most recently evolved region of the brain, the neocortex is particularly well developed in humans and is responsible for sensory processing, long-term memory, reasoning, complex muscle actions, consciousness and other functions.

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

Viewpoints: Dems vs. Ryan on entitlement cuts; defending planned parenthood

Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.

Read more Medical News

› Verified 1 days ago

Provider NameZaylee Otero-martinez
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1720504236
PECOS PAC ID: 2466888169
Enrollment ID: I20200128001963

News Archive

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists at The Scripps Research Institute have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex. The largest and most recently evolved region of the brain, the neocortex is particularly well developed in humans and is responsible for sensory processing, long-term memory, reasoning, complex muscle actions, consciousness and other functions.

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

Viewpoints: Dems vs. Ryan on entitlement cuts; defending planned parenthood

Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.

Read more Medical News

› Verified 1 days ago

Provider NameSherry Mae Carter
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1336751734
PECOS PAC ID: 4981014768
Enrollment ID: I20201105002539

News Archive

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists at The Scripps Research Institute have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex. The largest and most recently evolved region of the brain, the neocortex is particularly well developed in humans and is responsible for sensory processing, long-term memory, reasoning, complex muscle actions, consciousness and other functions.

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

Viewpoints: Dems vs. Ryan on entitlement cuts; defending planned parenthood

Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.

Read more Medical News

› Verified 1 days ago

Provider NameStacy Marie Humphreys
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1841698065
PECOS PAC ID: 3274948815
Enrollment ID: I20210212001530

News Archive

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists at The Scripps Research Institute have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex. The largest and most recently evolved region of the brain, the neocortex is particularly well developed in humans and is responsible for sensory processing, long-term memory, reasoning, complex muscle actions, consciousness and other functions.

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

Viewpoints: Dems vs. Ryan on entitlement cuts; defending planned parenthood

Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.

Read more Medical News

› Verified 1 days ago

News Archive

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists at The Scripps Research Institute have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex. The largest and most recently evolved region of the brain, the neocortex is particularly well developed in humans and is responsible for sensory processing, long-term memory, reasoning, complex muscle actions, consciousness and other functions.

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

Viewpoints: Dems vs. Ryan on entitlement cuts; defending planned parenthood

Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.

Read more News

› Verified 1 days ago

Psychologist in Lakeland, FL

Better Minds Counseling Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 6703 Krenson Oaks Cir, Lakeland, FL 33810
Phone: 786-319-2470    
Hull And Associates, P. A.
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 6700 S Florida Ave, Suite 11, Lakeland, FL 33813
Phone: 863-644-8241    Fax: 863-644-9025
Agape Counseling Services
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 6868 N Socrum Loop Rd, Lakeland, FL 33809
Phone: 863-687-6099    Fax: 863-858-1495
Downtown Counseling, P.a.
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 100 S Kentucky Ave, Ste 230, Lakeland, FL 33801
Phone: 863-660-6640    
Sanger And Associates - Behavioral And Psychological Services, Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2780 Verandah Vue Way, Lakeland, FL 33812
Phone: 863-944-0841    Fax: 863-583-0480
Whitesands Alcohol & Drug Rehab Lakeland
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 5135 Us Highway 98 N, Lakeland, FL 33809
Phone: 863-213-6711    
Better Life Counseling
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 930 Alicia Rd, Lakeland, FL 33801
Phone: 863-680-1950    Fax: 863-683-4654

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.